Prescription medication · Anticonvulsant (Barbiturate)
primidone
Also sold as Mysoline. Primidone is used to manage grand mal, psychomotor, and focal epileptic seizures.
Data updated 2026-05-15
- 9,782
- FDA reportsLightly reported
- 9
- InteractionsFew interactions
- 98% less
- Generic vs brandHuge savings
- 6
- Recall records
What the data shows
primidone (Mysoline) is a prescription Anticonvulsant (Barbiturate), reported less often than most tracked drugs (9,782 FDA reports), whose generic costs a fraction of the brand (about 98% less).
Reporting volume reflects how widely a drug is used and studied, not how dangerous it is, a FAERS report documents a temporal association, never proof of cause.
primidone (Mysoline) is a prescription Anticonvulsant (Barbiturate). Primidone is used to manage grand mal, psychomotor, and focal epileptic seizures.
Primidone is a medicine used to control seizures. It belongs to a class of drugs called anticonvulsants.
Verify with FDA → · CMS NADAC pricing →
Drug Pricing (NADAC)
Brand Price
$62.56/unit
Generic Price
$1.25/unit
Generic Savings
98%
Generic Available
Yes (7 manufacturers)
Pricing data from NADAC (CMS), effective December 18, 2024. Compare all drug costs →
What it does
Primidone is used to manage grand mal, psychomotor, and focal epileptic seizures.
Common side effects
Feeling unsteady, Dizziness, Drowsiness
Key warnings
You should not take primidone if you have porphyria or are allergic to phenobarbital.
The sections below are summarized in plain English from primidone's FDA-approved prescribing information. They describe what the official label says, and are not personal medical advice.
How It Works
Primidone works in the brain to reduce the frequency of seizures. It is similar to a barbiturate and helps to stabilize electrical activity. This can help prevent seizures from starting.
Side Effects (from patient reports)
Based on 9,782 FDA adverse event reports.
Most-reported reactions
Adverse reactions in FAERS for primidone, by number of reports
- Fall
Fall
651 reports
- Fatigue
Fatigue
616 reports
- Tremor
Tremor
568 reports
- Dizziness
Dizziness
484 reports
- Diarrhoea
Diarrhoea
480 reports
- Nausea
Nausea
458 reports
- Headache
Headache
385 reports
- Drug Interaction
Drug Interaction
378 reports
- Somnolence
Somnolence
377 reports
- Asthenia
Asthenia
353 reports
What this shows Bars show how often each reaction was reported, not how likely it is to happen, a report records a temporal association, never proof that the drug caused it.
Reports over time
Adverse-event reports filed for primidone each year to the FDA Adverse Event Reporting System (FAERS).
Year-to-year volume tracks usage, prescribing, and scrutiny, not a change in per-patient risk. Source: FDA FAERS.
Where primidone sits
primidone has more FDA adverse-event reports than 39% of the drugs FAERS tracks. A high position reflects how widely a drug is used and watched, not how dangerous it is.
Percentile across all drugs PlainMeds tracks by FAERS report volume. The dot is primidone; the line is the median (50th percentile).
FDA Adverse Event Report Analysis
Detailed analysis of 9,782 reports from the FDA Adverse Event Reporting System (FAERS). Reports span 2002–2025.
Total Reports
9,782
Reports Mentioning Death
850
8.7% of reports — not proof of cause
Hospitalization Reports
3,062
Top Indication
Product Used For Unknown Indication
Gender Distribution
Age Distribution
Most Reported Adverse Reactions (FAERS)
| # | Reaction | Reports |
|---|---|---|
| 2 | FALL | 651 |
| 3 | FATIGUE | 616 |
| 4 | TREMOR | 568 |
| 5 | DIZZINESS | 484 |
| 6 | DIARRHOEA | 480 |
| 8 | NAUSEA | 458 |
| 9 | HEADACHE | 385 |
| 10 | DRUG INTERACTION | 378 |
| 11 | SOMNOLENCE | 377 |
| 12 | ASTHENIA | 353 |
| 13 | DYSPNOEA | 349 |
| 14 | WEIGHT DECREASED | 321 |
| 15 | PAIN | 319 |
| 16 | PNEUMONIA | 297 |
| 17 | DEATH | 290 |
Reactions in Death Reports
Reactions in Hospitalization Reports
Source: FDA FAERS (Adverse Event Reporting System) Reports are voluntary and do not establish causation
Serious Warnings
You should not take primidone if you have porphyria or are allergic to phenobarbital.
Known Drug Interactions
Anticonvulsants carbamazepine , phenobarbital, primidone, phenytoin ↓ nirmatrelvir/ritonavir Co-administration contraindicated due to potential loss of virologic response and possible resistance [see Contraindications (4) ] .
Mechanism: Primidone makes your body break down nirmatrelvir/ritonavir too fast, which lowers the amount of medicine in your blood. This can make the treatment stop working and help the virus become harder to treat.
Drugs that have been shown, or that would be expected, to decrease plasma carbamazepine levels include cisplatin, doxorubicin HCl, felbamate, fosphenytoin, rifampin, phenobarbital, phenytoin, primidone, methsuximide, theophylline, aminophylline.
Mechanism: Primidone speeds up the liver's ability to break down carbamazepine, which lowers the amount of medicine in your blood.
7.5 Effects of Other Drugs on Folates Several drugs have been reported to reduce folate concentrations by inhibition of the dihydrofolate reductase enzyme (e.g., methotrexate and sulfasalazine) or by reducing folate absorption (e.g., cholestyramine), or via unknown mechanisms (e.g., antiepileptics such as carbamazepine, phenytoin, phenobarbital, primidone and valproic acid).
Mechanism: Primidone can lower the amount of folate (a B-vitamin) in your body through a process that is not yet fully understood.
Phenobarbital/Primidone ↓ lamotrigine Decreased lamotrigine concentration approximately 40%. ( 7 , 12.3 ) Carbamazepine, phenytoin, phenobarbital, primidone, and rifampin decrease lamotrigine concentrations by approximately 40%.
Mechanism: Primidone speeds up how fast your body breaks down lamotrigine, which lowers the amount of medicine in your blood.
Drugs which may interact with folate include: • Antiepileptic drugs (AED): The AED class including, but not limited to, phenytoin, carbamazepine, primidone, valproic acid, fosphenytoin, valproate, phenobarbital and lamotrigine have been shown to impair folate absorption and increase the metabolism of circulating folate.
Mechanism: Primidone interferes with how your body absorbs folate and speeds up how fast your body uses up the folate in your system.
This is a plain-language summary of FDA-label interaction records and does not provide individual medication-combination directions.
Common Questions
Can I stop taking primidone suddenly?
Will primidone interact with other medications I'm taking?
Can I drink alcohol while taking primidone?
How long does it take for primidone to start working?
What should I do if I experience side effects?
Can children take primidone?
Will primidone make me feel tired?
Does primidone cure epilepsy?
Can I take primidone if I have kidney problems?
Is it safe to drive while taking primidone?
What are the common side effects of primidone?
Does primidone interact with other medications?
What drug class is primidone?
Is there a generic version of primidone?
What pregnancy or breastfeeding source fields are listed for primidone?
Has primidone been recalled?
Active Recalls
Cross Contamination with Other Products: due to a potential for cross-contamination with Acemetacin API due to an issue at the API manufacturer.
Amneal Pharmaceuticals, LLC
Cross contamination with other products: API contaminated with trace amounts of Acemetacin API.
Amerisource Health Services LLC
Cross contamination with other products: API contaminated with trace amounts of Acemetacin API.
Amerisource Health Services LLC
Cross contamination with other products: API contaminated with trace amounts of Acemetacin API.
Golden State Medical Supply Inc.
Cross contamination with other products: API contaminated with trace amounts of Acemetacin API.
Golden State Medical Supply Inc.
Cross contamination with other products: API contaminated with trace amounts of Acemetacin API.
Lannett Company Inc.
Related Medications in Anticonvulsant (Barbiturate)
Other drugs grouped near primidone - same-class peers and common alternatives.
brivaracetam
Briviact
Brivaracetam is a medicine used to treat partial-onset seizures.
Compare with primidone →
cannabidiol
Epidiolex
Epidiolex is a medicine that contains cannabidiol.
Compare with primidone →
carbamazepine
Tegretol
Carbamazepine is a medicine used to control seizures and treat nerve pain.
Compare with primidone →
cenobamate
Xcopri
Xcopri is a medicine used to treat partial-onset seizures in adults.
Compare with primidone →
clobazam
Onfi, Sympazan
Clobazam oral suspension is a medicine used with other medicines to treat seizures caused by Lennox-Gastaut syndrome.
Compare with primidone →
Compare beyond drug class
Nationwide peers by FAERS volume & death-report share
Two PlainMeds-derived comparison paths for primidone: nearest FDA FAERS report volume and nearest death-report share among drugs with at least 1,000 logged reports, excluding same-class neighbors listed above. Counts reflect reporting volume, not proven individual harm.
Similar FAERS report volume
Nearest drugs by total FAERS reports. This record: 9,782.
Similar death-report share
Nearest drugs by FAERS death-report share. This record: 8.69%.
- sulfasalazine Δ 0.00 pts · 76,270 reports · Disease-Modifying Antirheumatic Drug (DMARD) 8.69%death share
- clarithromycin Δ 0.00 pts · 33,247 reports · Macrolide Antibiotic 8.69%death share
- finasteride Δ 0.01 pts · 56,567 reports · 5-Alpha Reductase Inhibitor 8.68%death share
- artificial tears Δ 0.04 pts · 2,450 reports · Ocular Lubricant 8.65%death share
Medication Guides
Understanding Drug Interactions
How CYP450 enzymes, inhibitors, and inducers affect your medications
Generic vs Brand Name Drugs
FDA requirements, cost savings, and when the difference matters
Narrow Therapeutic Index Drugs
FDA bioequivalence and label-record context for narrow therapeutic index medicines
Common Drug Interactions
Dangerous medication combinations and how to protect yourself
Save on primidone
Compare prices and find discounts at pharmacies near you. Free coupons can save up to 80% on prescriptions.
Disclosure: This link may earn us a commission at no extra cost to you. See our terms.
What the FDA Data Shows for primidone
The FDA label for primidone (sold under brand names such as Mysoline) classifies it as a prescription-only medication in the Anticonvulsant (Barbiturate) class. Primidone is used to manage grand mal, psychomotor, and focal epileptic seizures. Official labeling lists 3 commonly reported side effects, including Feeling unsteady, Dizziness, Drowsiness.
Post-market surveillance from the FDA Adverse Event Reporting System (FAERS) captures real-world experience. For this drug, FAERS contains 9,782 voluntary reports. The database also lists 9 documented drug interactions derived from FDA labeling, with the top-flagged interaction rated major severity. NADAC pricing from CMS shows a generic unit cost of $1.25 versus $62.56 for the brand - a 98% generic savings.
Report counts do not establish causation, a FAERS entry documents a temporal association, not proof that the drug produced the outcome. Widely prescribed medications naturally accumulate more reports than niche therapies, so raw totals must be interpreted alongside total exposure. Shortage status, recall history (currently 6 recall records on file), and patent information are separate source-record fields. This page is a public FDA/CMS registry and does not provide medical, treatment, substitution, or medication-change directions.
Data Sources
Drug labeling: FDA Drug Labels (SPL/DailyMed). Adverse events: FDA Adverse Event Reporting System (FAERS). Pricing: CMS National Average Drug Acquisition Cost (NADAC).
FAERS reports are voluntary and do not establish causation. Drug interactions are derived from FDA labeling and clinical references. This registry does not provide medication decisions.
Last updated: June 10, 2025
PlainMeds is rendered directly from FDA openFDA/FAERS extracts, DailyMed labels, and CMS drug-pricing files, no number is typed in by an editor. FAERS counts, recalls, shortages, and price figures on this page are queried live from those federal extracts. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-05-15. Primary sources: openFDA / FAERS, DailyMed and CMS Part B ASP.
Read our methodology - how this data is sourced, computed, and verified.
Data currency: FDA FAERS adverse-event reports through 2025, CMS NADAC acquisition-cost pricing effective December 2024, compiled from the source snapshot dated . See our methodology for per-source dates and refresh cadence. Spot a figure that looks wrong? Report a data issue.
All federal data sources used on this page
- FDA Orange Book - approved drug products with therapeutic equivalence. accessdata.fda.gov/cder/ob
- FDA DailyMed - NIH-hosted drug labeling for FDA-approved meds. dailymed.nlm.nih.gov
- FDA Adverse Event Reporting System (FAERS) - post-marketing safety surveillance. fda.gov/drugs/faers
- NLM RxNorm - standardized clinical drug nomenclature. nlm.nih.gov/research/umls/rxnorm
- CMS Medicare Part B Drug Average Sales Price Files - federal drug pricing data. cms.gov/medicare/part-b-drugs/asp
- FDA Drug Shortages Database - current and resolved drug shortage tracking. accessdata.fda.gov/drugshortages